These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8740577)

  • 1. 4-Pentafluoroethylumbelliferyl-beta-D-glucoside as a new fluorogenic substrate for acid beta-D-glucosidase.
    Tsvetkova IV; Karpova EA; Dudukina TV; Voznyi YV
    Clin Chim Acta; 1996 Apr; 248(2):125-33. PubMed ID: 8740577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Glucosidase assays in the diagnosis of Gaucher's disease.
    Daniels LB; Glew RH
    Clin Chem; 1982 Apr; 28(4 Pt 1):569-77. PubMed ID: 6804115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
    Mikhaylova M; Wiederschain G; Mikhaylov V; Aerts JM
    Biochim Biophys Acta; 1996 Oct; 1317(1):71-9. PubMed ID: 8876629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease.
    Svennerholm L; Håkansson G; Dreborg S
    Clin Chim Acta; 1980 Sep; 106(2):183-93. PubMed ID: 6773705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.
    Ben-Yoseph Y; Nadler HL
    J Clin Pathol; 1978 Nov; 31(11):1091-3. PubMed ID: 105017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
    Butcher BA; Gopalan V; Lee RE; Richards TC; Waggoner AS; Glew RH
    Clin Chim Acta; 1989 Oct; 184(3):235-42. PubMed ID: 2515009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygote detection of type I Gaucher disease using blood platelets.
    Nakagawa S; Kumin S; Sachs G; Nitowsky HM
    Clin Chim Acta; 1982 Jan; 118(1):99-107. PubMed ID: 6797762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and stability assay of 4-methylumbelliferyl (1-->3)-beta-D-pentaglucoside.
    Huang G
    J Enzyme Inhib Med Chem; 2009 Apr; 24(2):453-6. PubMed ID: 18608765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate.
    Chambers JP; Aquino L; Glew RH; Lee RE; McCafferty LR
    Clin Chim Acta; 1977 Oct; 80(1):67-77. PubMed ID: 20252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Glucosidase activities in the Norrbotten type of juvenile Gaucher's disease.
    Hultberg B
    Acta Neurol Scand; 1978 Aug; 58(2):89-94. PubMed ID: 30251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside.
    Broadhead DM; Butterworth J
    Clin Chim Acta; 1977 Feb; 75(1):155-61. PubMed ID: 14796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
    Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
    J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects.
    Michelin K; Wajner A; Goulart Lda S; Fachel AA; Pereira ML; de Mello AS; Souza FT; Pires RF; Giugliani R; Coelho JC
    Clin Chim Acta; 2004 May; 343(1-2):145-53. PubMed ID: 15115687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.
    Carroll M
    J Inherit Metab Dis; 1985; 8(1):33-7. PubMed ID: 3921758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease.
    Raghavan SS; Topol J; Kolodny EH
    Am J Hum Genet; 1980 Mar; 32(2):158-73. PubMed ID: 6770675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of beta-maltosides, derivatives of p-nitrophenol, 2-chloro-4-nitrophenol, and 4-methylumbelliferone, and their use as substrates for determining alpha-glucosidase activity].
    Voznyĭ IaV; Lukomskaia IS; Lanskaia IM; Podkidysheva EI
    Vopr Med Khim; 1996; 42(4):348-54. PubMed ID: 9254525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
    Wenger DA; Clark C; Sattler M; Wharton C
    Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
    Choy FY; Bouillon L; Laurin CA
    Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.